TORONTO, August 1, 2025 – Brian O’Callaghan, CEO of Deep Genomics, the AI-first TechBio organization pioneering a new path for genomic R&D, has been named Biotech Executive of the Year, winning gold in the second annual Stevie Awards for Technology Excellence. 

Since his appointment as ...

Cambridge, MA/Toronto CA – June 2, 2025 – Deep Genomics, the AI-first TechBio organization pioneering a new path for genomic R&D with its AI foundation model platform, have added two highly respected scientific leaders to its Scientific Advisory Board: Vic Myer, PhD, as Chair, and Richard ...

TORONTO, May 19, 2025, Deep Genomics, the AI-first TechBio organization pioneering a new path for genomic R&D, today announced the latest addition to its foundation model platform. The new deep learning model, REPRESS, accurately predicts microRNA (miRNA) binding and mRNA degradation directly from RNA sequences ...

Cambridge, MA/Toronto CA – April 14, 2025 – Deep Genomics, the AI-first TechBio organization pioneering a new path for genomic R&D with its AI foundation models platform, today announced two key executive hires joining the team amidst continued growth.  

• Monika Kowalczyk, MD, PhD, joins as Vice ...

Deep Genomics Awarded Stevies 2024 BioTechnology Company of the Year

Cambridge, MA– June 13, 2024 – Deep Genomics, the creator of BigRNA - the first AI foundation model for decoding RNA biology and designing therapeutics, today announced significant expansion milestones. The company celebrated the opening of its new office and lab facility in Cambridge, Massachusetts, the expansion ...

Company’s unique AI foundation model BigRNA is the first transformer neural network for the discovery of RNA biology and therapeutics

Represents a new generation of deep learning AI that can be applied to a range of different RNA therapeutic discovery tasks

Comprised of nearly ...